Results of applying A-Flex therapy in patients obstructive sleep apnea and metabolic syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Study objective. To investigate 6-month effects of CPAP therapy with auto-adaptation to inhalation and exhalation of obstructive sleep apnea (OSA) patient with MS (A-FLex therapy) on carbohydrate metabolism, lipid metabolism and blood pressure (BP). Materials and methods. To the prospective single-center study were included 30 (19 male [63,3%] и 11 female [36,7%], 51,70±11,54 year) OSA patients with MS and apnea-hypopnea index (AHI) >15 events/hour. The night polygraphy study (PG) was performed to calculate AHI, oxygen desaturation index (ODI), mean nocturnal saturation (Sp02 mean) by the rules of American academy of sleep medicine. Endothelial function of blood vessels determined by finger test was measured according to peripheral arterial tone (PAT). The reactive hyperemia index (RHI) and augmentation index (AI) was calculated. Optimal level of A-Flex therapy was adjusted at home. AHI, the level of air leakage, average pressure and compliance to CPAP treatment were established in accordance with international requirements. Results. After 6 months of A-Flex therapy we found a significant decrease of level of systolic and diastolic blood pressure (p=0,004), normalization of the level of glycated hemoglobin (HbA10 (p=0,03), normalization index of reactive hyperemia (RHI) (p=0.004), normalization of the augmentation index (AI) (p=0.003). There was statistically significant moderate strength (r=0.53; p<0.01) correlation between severity of sleep apnea (AHI) and level of vessel endothelium damage (RHI). There was a modest correlation (r=0,49; p<0.01) between severity of oxygen desaturations (ODI) and level of arterial stiffness (AI), associated with increased level of central BP and post load of the myocardium of the left ventricle. Conclusions. 6-month A-Flex therapy in OSA patients with MS has a significant therapeutic effect of stabilization systolic and diastolic blood pressure, level of blood lipids and glycated hemoglobin, level of endothelial dysfunction. The 6-month A-Flex therapy has to able to reduce the risks of cardiovascular events in moderate and severe OSA patients with acute metabolic manifestations.

Full Text

Restricted Access

About the authors

Marina V. Gorbunova

A.I. Yevdokimov Moscow State University of medicine and dentistry

Email: mgorb@mail.ru
PhD, associated professor, Department of phthisiology and pulmonology

Sergey L. Babak

A.I. Yevdokimov Moscow State University of medicine and dentistr

Email: sergbabak@mail.ru
MD, professor, Department of phthisiology and pulmonology

Andrey G. Malyavin

A.I. Yevdokimov Moscow State University of medicine and dentistry

Email: maliavin@mail.ru
MD, professor, Department of phthisiology and pulmonology

References

  1. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., Diener-West M., Sanders M.H., Wolf P.A., Geraghty E.M., Ali T., Lebowitz M., Punjabi N.M. Obstructive sleep apnoea-hypopnea and incident stroke: The Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2010:182:269-77.
  2. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., Redline S., Resnick H.E., Tong E.K., Diener-West M., Shahar E. Prospective study of obstructive sleep apnoea and incident coronary heart disease and heart failure: the Sleep Heart Health Study. Circulation. 2010:122:352-60.
  3. Ip M.S., Tse H.F., Lam B., Tsang K.W., Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am. J. Respir. Crit. Care Med. 2004:169:348-53.
  4. Nieto F.J., Herrington D.M., Redline S., Benjamin E.J., Robbins J.A. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am. J. Respir. Crit. Care Med. 2004:169:354-60.
  5. Stiefel P., Sanchez-Armengol M.A., Villar J., Vallejo-Vaz A., Moreno-Luna R., Capote F. Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles. Arch. Med. Res. 2013:44:409-14.
  6. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., Celermajer D.S. Treatment of obstructive sleep apnea leads to improved microvascular endothelial function in the systemic circulation. Thorax. 2006:6:491-5.
  7. Drager L.F., Togeiro S.M., Polotsky V.Y., Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J. Am. Coll. Cardiol. 2013;62(7): 569-76.
  8. Fava C., Montagnana M., Favaloro E.J., Guidi G.C., Lippi G. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin. Thromb. Hemost. 2011;37:280-97.
  9. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax. 2009;64:631-6.
  10. Grundy S.M., Brewer H.B. Jr., Cleeman J.I., Smith S.C. Jr., Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8.
  11. Kushida C.A., Littner M.R., Morgenthaler T., Alessi C.A., Bailey D., Coleman J. Jr., Friedman L., Hirshkowitz M., Kapen S., Kramer M., Lee-Chiong T., Loube D.L., Owens J., Pancer J.P., Wise M. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005;28:499-521.
  12. Littner M., Hirshkowitz M., Davila D., Anderson W.M., Kushida C.A., Woodson B.T., Johnson S.F., Merrill S.W. Standards of Practice Committee of the American academy of sleep medicine. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American academy of sleep medicine report. Sleep. 2002;25(2):143-7.
  13. Masa J.F., Jiménez A., Durán J., Capote F., Monasterio C., Mayos M., Terán J., Hernández L., Barbé F., Maimó A., Rubio M., Montserrat J.M. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am. J. Respir. Crit. Care Med. 2004:170:1218-24.
  14. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Sheffy J., Schnall R.P., Karas R.H., Udelson J.E. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am. Heart J. 2003;146(1):68-174.
  15. Onkelinx S., Cornelissen V., Goetschalckx K., Thomaes T., Verhamme P., Vanhees L. Reproducibility of different methods to measure the endothelial function. Vasc. Med. 2012;17(2):79-84.
  16. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M., Schmieder R.E., Sirnes P.A., Sleight P., Viigimaa M., Waeber B., Zannad F. The 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013:31:1281-357.
  17. Coughlin S.R., Mawdsley L., Mugarza J.A., Wilding J.P., Calverley P.M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur. Respir. J. 2007;29(4):720-7.
  18. Duran-Cantolla J., Aizpuru F., Montserrat J.M., Ballester E., Teran-Santos J., Aguirregomoscorta J.I., Gonzalez M., Lloberes P., Masa J.F., De La Pena M., Carrizo S., Mayos M., Barbé F.; Spanish Sleep and Breathing Group. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010;341:c5991.
  19. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., Merino-Sanchez M., Gonzalez-Benitez M.A., Beltran-Robles M., Almeida-Gonzalez C. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebocontrolled trial. Chest 2006;129(6):1459-67.
  20. Muxfeldt E.S., Margallo V., Costa L.M., Guimaräes G., Cavalcante A.H., Azevedo J.C., de Souza F., Cardoso C.R., Salles G.F. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension. 2015;65(4):736-42.
  21. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686-92.
  22. Nadeem R., Singh M., Nida M., Kwon S., Sajid H., Witkowski J., Pahomov E., Shah K., Park W., Champeau D. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J. Clin. Sleep Med.;10(12):1295-302.
  23. Steiropoulos P., Tsara V., Nena E., Fitili C., Kataropoulou M., Froudarakis M., Christaki P., Bouros D. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007;132(3):843-51.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies